FDA Inspection 1234878 — Baton Rouge General Medical Center Mid City

Baton Rouge General Medical Center Mid City — FEI 1000306914

The FDA completed an inspection of Baton Rouge General Medical Center Mid City on March 22, 2024 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 22, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Baton Rouge, LA (United States)